117 related articles for article (PubMed ID: 10718428)
21. Smoking, alcohol drinking, occupational exposures and social inequalities in hypopharyngeal and laryngeal cancer.
Menvielle G; Luce D; Goldberg P; Leclerc A
Int J Epidemiol; 2004 Aug; 33(4):799-806. PubMed ID: 15155704
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma.
Dikshit RP; Boffetta P; Bouchardy C; Merletti F; Crosignani P; Cuchi T; Ardanaz E; Brennan P
Cancer; 2005 Jun; 103(11):2326-33. PubMed ID: 15852357
[TBL] [Abstract][Full Text] [Related]
23. [Laryngeal cancer in Murcia].
Merino E; Hellín D; Girona JC; Arregui M; Jiménez-Cervantes J
Acta Otorrinolaringol Esp; 1994; 45(1):37-40. PubMed ID: 8204292
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
25. [Subjective attitudes of laryngectomized patients of the cause of the tumor disease. Correlation with psychosocial adjustment and pre- and postoperative alcohol and tobacco consumption].
de Maddalena H; Pfrang H
HNO; 1993 Apr; 41(4):198-205. PubMed ID: 8514526
[TBL] [Abstract][Full Text] [Related]
26. Significance of free radical injury in laryngeal and hypopharyngeal cancers.
Manjunath MK; Annam V; Suresh DR
J Laryngol Otol; 2010 Mar; 124(3):315-7. PubMed ID: 19930749
[TBL] [Abstract][Full Text] [Related]
27. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.
Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Hsu TC; Schantz SP
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1043-9. PubMed ID: 11045786
[TBL] [Abstract][Full Text] [Related]
28. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.
Ahrendt SA; Chow JT; Yang SC; Wu L; Zhang MJ; Jen J; Sidransky D
Cancer Res; 2000 Jun; 60(12):3155-9. PubMed ID: 10866304
[TBL] [Abstract][Full Text] [Related]
29. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic management of laryngeal cancer. Results of a study of 356 patients from the Cancer Registry of the Somme, France.
Ayache S; Peng J; Chatelain D; De La Roche Saint-Andre G; Mineur O; Raverdy N; Dubreuil A; Krzisch C; Strunski V
Acta Otolaryngol; 2005 Dec; 125(12):1323-6. PubMed ID: 16303682
[TBL] [Abstract][Full Text] [Related]
31. Five-year survival rates and time trends of laryngeal cancer in the US population.
Cosetti M; Yu GP; Schantz SP
Arch Otolaryngol Head Neck Surg; 2008 Apr; 134(4):370-9. PubMed ID: 18427002
[TBL] [Abstract][Full Text] [Related]
32. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
33. Factors predictive of survival in advanced laryngeal cancer.
Chen AY; Halpern M
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1270-6. PubMed ID: 18086971
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England.
Llewellyn CD; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2004 Oct; 33(9):525-32. PubMed ID: 15357672
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
36. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
[TBL] [Abstract][Full Text] [Related]
37. The role of acid and alkaline reflux in laryngeal squamous cell carcinoma.
Galli J; Cammarota G; Calò L; Agostino S; D'Ugo D; Cianci R; Almadori G
Laryngoscope; 2002 Oct; 112(10):1861-5. PubMed ID: 12368631
[TBL] [Abstract][Full Text] [Related]
38. T1 glottic carcinoma involving the posterior commissure.
Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
[TBL] [Abstract][Full Text] [Related]
39. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors for the development of lung tumors after liver transplantation.
Jiménez C; Manrique A; Marqués E; Ortega P; Loinaz C; Gómez R; Meneu JC; Abradelo M; Moreno A; López A; Moreno E
Transpl Int; 2007 Jan; 20(1):57-63. PubMed ID: 17181654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
